Anti-CAH6/ CA-VI/ CA6 functional antibody

Anti-CAH6/ CA-VI/ CA6 functional antibody for cell culture, ELISA & in-vivo assay

Target products collectionGo to CA-VI/CA6 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-T06569-Ab-1/ GM-Tg-hg-T06569-Ab-2Anti-Human CA-VI/CA6 monoclonal antibodyHuman
GM-Tg-rg-T06569-Ab-1/ GM-Tg-rg-T06569-Ab-2Anti-Rat CA-VI/CA6 monoclonal antibodyRat
GM-Tg-mg-T06569-Ab-1/ GM-Tg-mg-T06569-Ab-2Anti-Mouse CA-VI/CA6 monoclonal antibodyMouse
GM-Tg-cynog-T06569-Ab-1/ GM-Tg-cynog-T06569-Ab-2Anti-Cynomolgus/ Rhesus macaque CA-VI/CA6 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-T06569-Ab-1/ GM-Tg-felg-T06569-Ab-2Anti-Feline CA-VI/CA6 monoclonal antibodyFeline
GM-Tg-cang-T06569-Ab-1/ GM-Tg-cang-T06569-Ab-2Anti-Canine CA-VI/CA6 monoclonal antibodyCanine
GM-Tg-bovg-T06569-Ab-1/ GM-Tg-bovg-T06569-Ab-2Anti-Bovine CA-VI/CA6 monoclonal antibodyBovine
GM-Tg-equg-T06569-Ab-1/ GM-Tg-equg-T06569-Ab-2Anti-Equine CA-VI/CA6 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-T06569-Ab-1/ GM-Tg-hg-T06569-Ab-2; GM-Tg-rg-T06569-Ab-1/ GM-Tg-rg-T06569-Ab-2;
GM-Tg-mg-T06569-Ab-1/ GM-Tg-mg-T06569-Ab-2; GM-Tg-cynog-T06569-Ab-1/ GM-Tg-cynog-T06569-Ab-2;
GM-Tg-felg-T06569-Ab-1/ GM-Tg-felg-T06569-Ab-2; GM-Tg-cang-T06569-Ab-1/ GM-Tg-cang-T06569-Ab-2;
GM-Tg-bovg-T06569-Ab-1/ GM-Tg-bovg-T06569-Ab-2; GM-Tg-equg-T06569-Ab-1/ GM-Tg-equg-T06569-Ab-2
Products NameAnti-CA-VI/CA6 monoclonal antibody
Formatmab
Target NameCA-VI
Protein Sub-locationSecreted Protein/Potential Cytokines
Category of antibodyFACS/Biofunctional Antibody, Therapeutics Target antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-CA-VI benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-T06569-Ag-1Recombinant multi-species CAH6/ CA-VI/ CA6 protein


    Target information

    Target IDGM-T06569
    Target NameCA-VI
    Gene ID765,12353,298657,709540,403503,101097328,280742,100051818
    Gene Symbol and SynonymsCA-VI,CA6,Car6,DOC1,GUSTIN
    Uniprot AccessionP23280,Q865C0,P18915
    Uniprot Entry NameCAH6_HUMAN,CAH6_CANLF,CAH6_BOVIN
    Protein Sub-locationSecreted Protein/Potential Cytokines
    CategoryTherapeutics Target
    DiseaseN/A
    Gene EnsemblENSG00000131686
    Target ClassificationN/A

    The target: CA-VI, gene name: CA6, also named as CA-VI, GUSTIN. The protein encoded by this gene is one of several isozymes of carbonic anhydrase. This protein is found only in salivary glands and saliva and protein may play a role in the reversible hydratation of carbon dioxide though its function in saliva is unknown. [provided by RefSeq, Jul 2008].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.